Clinical trial
A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced…
NCT00354562 · Abbott, Industry · Terminated
Key facts
| NCT number | NCT00354562 |
|---|---|
| Title | A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer |
| Official title | A Phase 1/2 Study Evaluating the Safety and Efficacy of ABT-751 in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer |
| Lead sponsor | Abbott, Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer, Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | ABT-751, Placebo, Docetaxel |
| Enrollment | 75 |
| Start date | Feb 1, 2007 |
| Primary completion | Feb 1, 2008 |
| First posted | Jul 20, 2006 |
| Last update posted | Jan 7, 2011 |
| Countries | Canada, Ireland, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: